These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 7060628)

  • 21. Antithrombotic effects of MK-0852, a platelet fibrinogen receptor antagonist, in canine models of thrombosis.
    Ramjit DR; Lynch JJ; Sitko GR; Mellott MJ; Holahan MA; Stabilito II; Stranieri MT; Zhang G; Lynch RJ; Manno PD
    J Pharmacol Exp Ther; 1993 Sep; 266(3):1501-11. PubMed ID: 8371153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of diltiazem and propranolol on left ventricular segmental relaxation during temporary coronary arterial occlusion and one month reperfusion in conscious dogs.
    Tilton GD; Bush LR; Apprill PG; Buja LM; Willerson JT
    Circulation; 1985 Jan; 71(1):165-75. PubMed ID: 3964719
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diltiazem at reperfusion reduces neutrophil accumulation and infarct size in dogs with ischaemic myocardium.
    Rousseau G; St-Jean G; Latour JG; Merhi Y; Nattel S; Waters D
    Cardiovasc Res; 1991 Apr; 25(4):319-29. PubMed ID: 1884391
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Myocardial protection through cold cardioplegia with potassium or diltiazem. Experimental evidence that diltiazem provides better protection even when coronary flow is impaired by a critical stenosis.
    Vouhé PR; Hélias J; Robert P; Grondin CM
    Circulation; 1982 Jun; 65(6):1078-85. PubMed ID: 7074770
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Temporary and partial inhibition of platelets by SM-20302 prevents coronary artery thrombosis in a chronic canine model.
    Huang J; Rebello SS; Rosenberg LA; Kaneko M; Sakurama T; Lucchesi BR
    Eur J Pharmacol; 1999 Feb; 366(2-3):203-13. PubMed ID: 10082201
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reduction of in vivo coronary artery thrombosis by the novel thromboxane antagonist (3R)-3-(4-fluorophenylsulfonamido)-1,2,3,4-tetrahydro-9- carbazolepropanoic acid.
    Fiedler VB; Perzborn E; Seuter F; Rosentreter U; Böshagen H
    Arzneimittelforschung; 1989 Dec; 39(12):1527-30. PubMed ID: 2624600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The effect of two different diltiazem treatments on infarct size in ischemic, reperfused porcine hearts.
    Klein HH; Schubothe M; Nebendahl K; Kreuzer H
    Circulation; 1984 May; 69(5):1000-5. PubMed ID: 6705155
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of diltiazem, a calcium antagonist, on myocardial ischemia.
    Weishaar R; Ashikawa K; Bing RJ
    Am J Cardiol; 1979 Jun; 43(6):1137-43. PubMed ID: 443173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmented mean systolic ejection rate in coronary patients treated with diltiazem.
    Kannagi T; Hossack KF; Kusumi F; Bruce RA
    Cardiology; 1983; 70(2):102-9. PubMed ID: 6871894
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of the combination of diltiazem and atenolol on exercise-induced regional myocardial ischemia in conscious dogs.
    Matsuzaki M; Guth B; Tajimi T; Kemper WS; Ross J
    Circulation; 1985 Jul; 72(1):233-43. PubMed ID: 4006133
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of ischemia-induced myocardial necrosis in the rat with permanent coronary artery occlusion under the effect of diltiazem.
    Zamanis A; Verdetti J; de Leiris J
    J Mol Cell Cardiol; 1982 Jan; 14(1):53-62. PubMed ID: 7062347
    [No Abstract]   [Full Text] [Related]  

  • 32. Reperfusate composition: benefits of marked hypocalcemia and diltiazem on regional recovery.
    Allen BS; Okamoto F; Buckberg GD; Acar C; Partington M; Bugyi H; Leaf J
    J Thorac Cardiovasc Surg; 1986 Sep; 92(3 Pt 2):564-72. PubMed ID: 3747584
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Failure of thromboxane synthetase inhibition to protect the postinfarcted heart against the induction of ventricular tachycardia and ventricular fibrillation in a conscious canine model of sudden coronary death.
    Kitzen JM; Lynch JJ; Uprichard AC; Venkatesh N; Lucchesi BR
    Pharmacology; 1988; 37(3):171-86. PubMed ID: 3227051
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diltiazem--a new calcium antagonist.
    Folb PI
    S Afr Med J; 1984 Jul; 66(3):83-4. PubMed ID: 6740436
    [No Abstract]   [Full Text] [Related]  

  • 35. Protective effects on isolated hearts with developing infarction: slow channel blockade by diltiazem versus beta-adrenoceptor antagonism by metoprolol.
    Hamm CW; Thandroyen FT; Opie LH
    Am J Cardiol; 1982 Oct; 50(4):857-63. PubMed ID: 6127029
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effects of diltiazem on rest and stress hemodynamics in coronary disease].
    Biamino G; Oeff M; Schröder R
    Z Kardiol; 1984 Aug; 73(8):504-9. PubMed ID: 6495810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prevention of rethrombosis after coronary thrombolysis in a chronic canine model. II. Adjunctive therapy with r-hirudin.
    Rote WE; Mu DX; Bates ER; Nedelman MA; Lucchesi BR
    J Cardiovasc Pharmacol; 1994 Feb; 23(2):203-11. PubMed ID: 7511748
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Simultaneous administration of digoxin and diltiazem in patients with cardiac insufficiency and coronary heart disease].
    Pfeiffer G
    Fortschr Med; 1985 Jul; 103(26):699-702. PubMed ID: 3899880
    [No Abstract]   [Full Text] [Related]  

  • 39. [Combined treatment of coronary heart disease with diltiazem and isosorbide dinitrate].
    Beythien RD
    Dtsch Med Wochenschr; 1983 Feb; 108(5):176-80. PubMed ID: 6402353
    [No Abstract]   [Full Text] [Related]  

  • 40. Diltiazem: the latest calcium-channel blocker.
    Kesten KS; Reuter NS; Swisher JD
    Dimens Crit Care Nurs; 1984; 3(3):154-60. PubMed ID: 6562003
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.